Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Supriya Lifescience LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543434NSE Symbol: SUPRIYAP/E(TTM):31.08
ISIN Demat:INE07RO01027Div & Yield %:0.15EPS(TTM):22.13
Book Value(Rs):123.8475252Market Cap ( Cr.):5535.2Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 781.92646.93516.47588.52430.97311.64
Excise Duty85.4476.5955.5358.4739.760.00
Net Sales696.48570.34460.94530.05391.21311.64
Other Income 9.8210.649.497.585.0111.07
Stock Adjustments 21.26-30.316.513.0312.4413.90
Total Income727.56550.67476.94540.66408.66336.61
EXPENDITURE :      
Raw Materials 232.44191.43187.32198.83140.57152.38
Power & Fuel Cost24.8021.3720.9514.079.248.97
Employee Cost 80.5267.6455.5849.0832.7618.88
Other Manufacturing Expenses 51.8135.6828.8718.4413.158.27
Selling and Administration Expenses 54.6538.1037.3233.8331.8830.10
Miscellaneous Expenses 12.619.808.514.842.928.56
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure456.83364.01338.55319.09230.51227.15
Operating Profit270.73186.65138.38221.56178.15109.45
Interest 1.815.153.084.204.086.85
Gross Profit268.92181.50135.30217.36174.07102.60
Depreciation20.4415.8111.8210.126.766.41
Profit Before Tax248.48165.69123.48207.24167.3196.19
Tax56.6637.1030.6852.1943.0225.07
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax3.879.482.953.250.69-2.23
Reported Net Profit187.96119.1189.86151.81123.5973.35
Extraordinary Items -0.010.00-0.080.000.000.00
Adjusted Net Profit187.97119.1189.94151.81123.5973.35
Adjst. below Net Profit 0.000.000.000.000.00-3.36
P & L Balance brought forward600.45486.16401.13253.72134.0879.08
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 6.444.834.834.393.9614.64
P & L Balance carried down781.97600.45486.16401.13253.72134.43
Dividend0.000.000.000.000.0014.64
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %50.0040.0030.0030.0027.00100.00
Earnings Per Share-Unit Curr23.3514.8011.1618.8616.8950.11
Earnings Per Share(Adj)-Unit Curr23.3514.8011.1618.86NANA
Book Value-Unit Curr123.84101.3186.9176.5036.70101.84